Page last updated: 2024-12-06

4-vinyl-2,6-dimethoxyphenol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-vinyl-2,6-dimethoxyphenol: isolated from canola oil; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID35960
CHEBI ID197097
SCHEMBL ID727024
MeSH IDM0470567

Synonyms (30)

Synonym
phenol, 4-ethenyl, 2,6-dimethoxy
4-ethenyl-2,6-dimethoxyphenol
4-vinylsyringol
CHEBI:197097
AKOS006280218
canolol
phenol, 4-ethenyl-2,6-dimethoxy-
zb5ok5ex8b ,
28343-22-8
unii-zb5ok5ex8b
2,6-dimethoxy-4-vinylphenol
vinylsyringol
31872-14-7
SCHEMBL727024
3,5-dimethoxy-4-hydroxystyrene (4-vinylsyringol)
QHJGZUSJKGVMTF-UHFFFAOYSA-N
DTXSID30865427
AS-44341
mfcd02094170
4-vinyl-2,6-dimethoxyphenol
2,6-dimethoxy-4-ethenylphenol
phenol, 2,6-dimethoxy-4-vinyl-
syringlyethene
phenol, 2,6-dimethoxy-4-ethenyl-
3,5-dimethoxy-4-hydroxystyrene
Q15634956
AMY10855
EN300-95459
CS-0217967
HY-W160560

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Due to lipophilic nature, canolol is an excellent orally bioavailable phenol."( INHIBITORY MECHANISM AGAINST OXIDATIVE STRESS AND BIOLOGICAL ACTIVITIES OF CANOLOL.
Li, H; Li, L; Li, P; Tan, XI; Wang, H; Wang, Z; Zhai, X; Zhang, H; Zhang, J; Zheng, C, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
methoxybenzenesAny aromatic ether that consists of a benzene skeleton substituted with one or more methoxy groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (16.67)29.6817
2010's16 (66.67)24.3611
2020's4 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.83

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.83 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index5.12 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.83)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (4.00%)5.53%
Reviews1 (4.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (92.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]